The central estimate is that B.1.1.7 carries a 30 to 40 per cent higher chance of dying. The impact of this relative risk on an individual will depend critically on his or her absolute risk — determined above all by age and then by underlying health and other factors. The evidence considered by Nervtag suggests that the variant increases case fatality rates consistently across all age groups.
It is worth remembering that fatality rates are already considerably lower than they were in the first wave of the pandemic in the spring, because health workers have learned how best to treat Covid-19 patients, including when to give dexamethasone steroid to those who are severely ill. Even if the new variant raises risk of death by 35 per cent, it would still be lower than for someone with the original form of the virus back in March
富江姊妹
2021-1-27 12:29:01
見唔見到有underlying other factors
:^(
醫療系統負擔唔到都無辦法
:^(
你要咁樣對比不如對比菲律賓 感染武漢肺炎嘅情況
富江姊妹
2021-1-27 12:29:47
點解死都唔肯睇大數據呢？
:^(
已經好確切話咗俾你聽個情況
:^(
英梓傑是小偷
2021-1-27 12:30:30
無人話武漢肺炎好似伊波拉咁
傳染力高左，病毒本身死亡率高左係事實
唔好再𧦠辯，篇文樓主都認證
The central estimate is that B.1.1.7 carries a 30 to 40 per cent higher chance of dying. The impact of this relative risk on an individual will depend critically on his or her absolute risk — determined above all by age and then by underlying health and other factors. The evidence considered by Nervtag suggests that the variant increases case fatality rates consistently across all age groups.
It is worth remembering that fatality rates are already considerably lower than they were in the first wave of the pandemic in the spring, because health workers have learned how best to treat Covid-19 patients, including when to give dexamethasone steroid to those who are severely ill. Even if the new variant raises risk of death by 35 per cent, it would still be lower than for someone with the original form of the virus back in March